Perinephric abscess: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 2: | Line 2: | ||
{{CMG}}{{AE}}:{{AK}} | {{CMG}}{{AE}}:{{AK}} | ||
*For perinephric abscess associated with [[bacteremia]] (staphylococcus is the causative organism): | |||
{| | |||
| valign=top | | |||
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:25em" cellpadding="0" cellspacing="0"; | |||
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B| Perinephric Abscess+ Bacteremia<br>Drainage and Aspiration}}'' | |||
|- | |||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''MSSA'' | |||
|- | |||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Nafcillin]] 2 gm IV q4h '''''<br>OR<br>'''''▸[[Oxacillin]] 2 gm IV q4h'''''<br>OR<br>▸ '''''[[Cefazolin]] 2 gm IV q8h''''' | |||
|- | |||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''MRSA'' | |||
|- | |||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''''▸ IV [[Vancomycin]]15-20 mg/kg q8-12h''''' | |||
|- | |||
|} | |||
|} | |||
*If Enterobacteriaceae is the causative pathogen(associated with pyelonephritis), treatment regimen will be the same as [[complicated pyelonephritis]] after abscess drainage and surgical or image guided aspiration. | |||
{| | |||
| valign=top | | |||
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:25em" cellpadding="0" cellspacing="0"; | |||
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B| Perinephric Abscess+Complicated Pyelonephritis}}'' | |||
|- | |||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen(2-3 weeks)+drainage and aspiration''† | |||
|- | |||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin-gentamicin]] 150–200 mg/kg IV/day-MDD: 2 mg per kg load, then 1.7 mg per kg q8h or OD: 5.1 (7 if critically ill) mg/kg q24h'''''<br>OR<br>'''''▸[[Piperacillin-tazobactam]] 3.375 gm IV 6h'''''<br>OR<br>▸ '''''[[Ticarcillin-clavulanate]] 3.1 gm IV q6h'''''<br>OR<br>'''''▸[[Carbapenems]]:<br>[[Doripenem]] 500 mg IV q8h (1 hr infusion for 10 days)<br>OR<br>[[Imipenem]] 0.5 gm IV q12h (max 4 gm/day<br>OR<br>[[Meropenem]] 1 gm IV q8h''''' | |||
|- | |||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Alternative Regimen(2-3 weeks)+drainage and aspiration''† | |||
|- | |||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''''▸ IV [[Fluoroquinolones]]:<br>[[Ciprofloxacin]] 400 mg IV q12h<br>OR<br>[[Levofloxacin]] 750 mg IV/po x 5 days<br>OR<br>[[Gatifloxacin]] 400 mg IV q24h'''''<br>OR<br>'''''▸[[Ceftazidime]] 2 gm IV q8h'''''<br>OR<br>'''''▸[[Cefepime]] 2 gm IV q12h''''' | |||
|- | |||
|} | |||
|} | |||
†Switch to oral [[fluoroquinolone]] or [[TMP-SMX]] when possible. | |||
Line 14: | Line 47: | ||
{{ | |||
{{Reflist|2}} |
Latest revision as of 12:18, 31 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: :Abdurahman Khalil, M.D. [2]
- For perinephric abscess associated with bacteremia (staphylococcus is the causative organism):
|
- If Enterobacteriaceae is the causative pathogen(associated with pyelonephritis), treatment regimen will be the same as complicated pyelonephritis after abscess drainage and surgical or image guided aspiration.
|
†Switch to oral fluoroquinolone or TMP-SMX when possible.